(6S)-2-[(3-Chloro-4-fluorophenyl)methyl]-8-ethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-N,6-dimethyl-1,9-dioxopyrazino[1',2':1,5]pyrrolo[2 ,3-d]pyridazine-4-carboxamide
CAS: 869901-69-9
Ref. 3D-FC104197
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar |
Informação sobre produto
- Pyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide, 2-[(3-chloro-4-fluorophenyl)methyl]-8-ethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-N,6-dimethyl-1,9-dioxo-, (6S)-
- (6S)-2-[(3-Chloro-4-fluorophenyl)methyl]-8-ethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-N,6-dimethyl-1,9-dioxopyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide
(6S)-2-[(3-Chloro-4-fluorophenyl)methyl]-8-ethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-N,6-dimethyl-1,9-dioxopyrazino[1',2':1,5]pyrrolo[2 ,3-d]pyridazine-4-carboxamide is a hydroxylated metabolite of the drug erythromycin. It has been shown to be effective in the treatment of bowel disease and cancer. The optical system of this drug is unique in that it is able to bind to DNA and inhibit the synthesis of proteins vital for cell division. This drug also has a high affinity for proteins with an alkylthio group or carbonyl group. The chemical structure of this drug makes it particularly useful as a diagnostic agent for inflammatory bowel disease and congestive heart
Propriedades químicas
Consulta técnica sobre: 3D-FC104197 (6S)-2-[(3-Chloro-4-fluorophenyl)methyl]-8-ethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-N,6-dimethyl-1,9-dioxopyrazino[1',2':1,5]pyrrolo[2 ,3-d]pyridazine-4-carboxamide
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.